Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.33 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18919387 | 0.98 | BBOX1 (0.36) | BBOX1LMNAALKBH5SUCNR1EGLN1 | |
| Bromide SCHEMBL3187118 | 0.84 | TSHR (0.44) | BBOX1LMNASLC22A6 | |
| Bromide SCHEMBL3197897 | 0.84 | TSHR (0.44) | BBOX1LMNASLC22A6 | |
| SCHEMBL4690450 | 0.82 | TSHR (0.46) | BBOX1LMNASLC22A6 | |
| SCHEMBL6209228 | 0.82 | TSHR (0.46) | BBOX1LMNASLC22A6 | |
| SCHEMBL19026195 | 0.75 | KDM4E (0.35) | SMN1; SMN2GLA | |
| Bromide SCHEMBL16968721 | 0.71 | — | — | |
| Bromide SCHEMBL19514188 | 0.69 | — | — | |
| SCHEMBL4903183 | 0.69 | PTK2 (0.50) | — | |
| SCHEMBL3483406 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080057113-A1 | Pharmaceutical Anti-Herpetic Composition, Method for Producing a Dosage Form Based Thereon and Method for the Use Thereof | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "RUSGEN" (RU) | 2008-03-06 | — | — | US | disclosed |
| EP-1693067-A1 | PHARMACEUTICAL ANTI-HERPETIC COMPOSITION, METHOD FOR PRODUCING A DOSAGE FORM BASED THEREON AND METHOD FOR THE USE THEREOF | Obschestvo S Ogranichennoi Otvetstvennostyu "Rusgen" (RU) | 2006-08-23 | — | — | EP | disclosed |